Skip to content
Open access

Genomic profile and infection dynamics of Kashi_RDG1 (KRDG1), a novel cluster K1 mycobacteriophage infecting mycobacterial hosts

Jul 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 60 references
Medicine

TL;DR

While KRDG1 exhibits temperate characteristics, its close genomic similarity to previously engineered therapeutic phage (ZoeJ) highlights its potential for future genetic engineering and therapeutic exploration against pathogenic mycobacterial and non-mycobacterial infections.

Abstract

Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global health challenge, particularly due to the increasing emergence of multidrug-resistant strains and limited treatment options. Bacteriophages have gained attention as potential alternatives or adjuncts to conventional antibiotics owing to their host specificity and antibacterial efficacy. Methods This study reports the isolation and detailed characterization of mycobacteriophage Kashi_RDG1 (KRDG1), isolated using Mycobacterium smegmatis mc2155. Genomic analysis, transmission electron microscopy, host range analysis, one-step growth assay, adsorption assay, multiplicity of infection (MOI) determination, and infection kinetics were performed to characterize the phage. Results Genomic analysis identified KRDG1 as sub cluster K1 mycobacteriophage, with a genome size of 58,681 bp containing 95 predicted open reading frames (ORFs), of which 39 are functionally annotated. Transmission electron microscopy analysis confirmed its siphovirus-like morphology while host range analysis depicted its polyvalent activity against Mycobacterium fortuitum (opportunistic pathogen) and M. tuberculosis H37Ra (an attenuated Mtb strain) in addition to M. smegmatis. One-step growth analysis revealed latent period of 80 min and burst size of 100 phage/bacterial cell supporting its efficient infection dynamics. Notably, infection kinetics demonstrated strong host bacterial killing during the logarithmic phase. Discussion While KRDG1 exhibits temperate characteristics, its close genomic similarity to previously engineered therapeutic phage (ZoeJ) highlights its potential for future genetic engineering and therapeutic exploration against pathogenic mycobacterial and non-mycobacterial infections.

Read PDF

Similar papers

Open access Aug 2026

The virulent phage vB_KpnP_JYSS5 and its depolymerase Dep11 targeting K57 Klebsiella pneumoniae: characterization and therapeutic potential against biofilm and systemic infection

Klebsiella pneumoniae frequently causes hospital-acquired and community-acquired infections, posing a serious threat to human health. Lytic phages can rapidly propagate within host bacterial cells and release progeny phages, ultimately inducing the death of the host bacteria. K. pneumoniae depolymerases are...

Jie Wang, Lu Zhang, Shi-Yan Jiao et al. · 0 citations
Open access Sep 2026

Characterization of Novel Mycobacteriophages of Subcluster A3: Evolutionary Plasticity of the Lysogeny Module and Lytic Potential

Findings highlight lysogeny module plasticity in closely related phages and position Cat, with its naturally occurring repressor deletion and potent lytic activity, as a promising candidate against drug-resistant tuberculosis.

M. Zaychikova, Maja Malakhova, S. Kuznetsova et al. · 0 citations
Aug 2026

Characterization and classification of a novel bacteriophage, vB_RsoP_HXg1W, infecting Ralstonia pseudosolanacearum: a new member of the genus Serkorvirus in the family Autotranscriptaviridae

These findings contribute to the understanding of RSSC-infecting phages and provide a foundation for further exploration of phage evolution, host range, and biocontrol relevant traits.

Xiaoli Yu, Zheng Fang, Qingshan Wu et al. · 0 citations
#software testing Open access Sep 2026

Genomic and phenotypic characterization of Klebsiella pneumoniae phage KP Ø1: a novel lytic Slopekvirus targeting uropathogenic multidrug-resistant Klebsiella pneumoniae

Klebsiella pneumoniae phage KP Ø1 is a novel, obligately lytic Slopekvirus whose genomic architecture, stability profile, and absence of lysogeny-associated, virulence, and antimicrobial resistance genes collectively support its candidacy for further preclinical evaluation as a phage therapy agent against uropathogenic...

Reham Fadl, Ghada Ismail, A. Elshafei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.